Lobe Sciences Ltd. (CVE:LOBE) | Finanzwire

Basculer en Français

9474	Companies
185433	Keywords
117775	Articles
99293	Press releases

Home
Companies
Lobe Sciences Ltd.

BRIEF

published on 07/29/2025 at 06:15, 4 months 7 days ago

Lobe Sciences Announces Private Placement for Corporate Funding

Private Placement Biopharmaceutical Investments Corporate Funding Lobe Sciences
BRIEF

published on 07/29/2025 at 06:13, 4 months 7 days ago

Lobe Sciences Ltd. Partners with ArcStone for Market Strategy

Investor Relations Strategic Partnership Capital Markets Biopharmaceutical Market Positioning
PRESS RELEASE

published on 07/29/2025 at 06:10, 4 months 7 days ago

Lobe Sciences Announces $341,425 CAD Private Placement for General Corporate Purposes
Lobe Sciences announces non-brokered private placement offering of common shares for gross proceeds, focusing on therapeutics for rare diseases

Private Placement Biopharmaceutical Therapeutics Rare Diseases Lobe Sciences
PRESS RELEASE

published on 07/29/2025 at 06:08, 4 months 7 days ago

Lobe Sciences Ltd. Engages ArcStone Securities for Strategic Capital Markets Advisory
Lobe Sciences partners with ArcStone Securities to enhance capital market strategy, aiming to increase visibility and deliver shareholder value through scientific innovation and strategic collaboration in North American markets

Capital Markets Biopharmaceutical Investment Community Lobe Sciences ArcStone Securities
BRIEF

published on 07/17/2025 at 04:00, 4 months 19 days ago

Lobe Sciences Ltd. Settles Debt with Gibbsons P.C.

Common Shares Issuance Debt Settlement Biopharmaceutical Company Canadian Securities Innovative Treatments
PRESS RELEASE

published on 07/17/2025 at 03:55, 4 months 19 days ago

Lobe Sciences Ltd. Announces Debt Settlement
Lobe Sciences settles debt with Gibbsons Law P.C. by issuing 546,206 common shares at CAD$0.02123/share. The shares were issued on May 13, 2025, subject to regulatory hold periods

Common Shares Debt Settlement Biopharmaceutical Lobe Sciences Regulatory Hold Periods
BRIEF

published on 07/08/2025 at 06:06, 4 months 28 days ago

Lobe Sciences Secures European Patent for Sickle Cell Disease Treatment

European Patent Sickle Cell Disease DHA Composition Altemia® Biopharmaceutical Expansion
PRESS RELEASE

published on 07/08/2025 at 06:01, 4 months 28 days ago

Lobe Sciences Announces Validation of European Unitary Patent for DHA-Based Composition for Sickle Cell Disease
Lobe Sciences secures European Unitary Patent EP4117446 across 17 EU member states for innovative Altemia(R) Medical Food Formula designed to manage Sickle Cell Disease, supporting global expansion strategy

Global Expansion Lobe Sciences Sickle Cell Disease European Unitary Patent Altemia Medical Food Formula
BRIEF

published on 06/18/2025 at 06:03, 5 months 17 days ago

Lobe Sciences Advances Conjugated Psilocin Development with Cynaptec Spin-Out

Conjugated Psilocin Cynaptec Pharmaceuticals Chronic Cluster Headaches Sickle Cell Disease Biopharmaceutical Investments
PRESS RELEASE

published on 06/18/2025 at 05:58, 5 months 17 days ago

Lobe Sciences Moves Forward with Development of Conjugated Psilocin(TM) Following April 14 Agreement to Spin Out Compound to Cynaptec Pharmaceuticals
Lobe Sciences Ltd. advances Conjugated Psilocin™ research for chronic cluster headaches and addiction via $6M investment in Cynaptec Pharmaceuticals, with option for additional $20M

Clinical Trials Investment Cynaptec Pharmaceuticals Lobe Sciences Ltd. Conjugated Psilocin™

Accesswire

Published on 12/05/2025 at 02:35, 8 hours 2 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 8 hours 7 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 9 hours 37 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 11 hours 32 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 11 hours 37 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 10:15, 22 minutes ago

Wuxi’s Liangxi District: Where 3,000 Years of Jiangnan Culture Thrives
Published on 12/05/2025 at 09:40, 56 minutes ago

Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 1 hour 7 minutes ago

REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 09:05, 1 hour 31 minutes ago

Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 09:00, 1 hour 36 minutes ago

Original-Research: DEMIRE AG (von NuWays AG): BUY

Les Echos

Published on 12/05/2025 at 08:45, 1 hour 52 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 16 hours 37 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 16 hours 52 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 16 hours 53 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 3 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE